XtalPi (HKG:2228) has received approval from the Hong Kong Stock Exchange to be regarded as a "commercial company" as opposed to a "pre-commercial company" previously.
Following the approval, the biotechnology firm will no longer have the "P" marker affixed to its English and Chinese stock short name. The new English stock short name will be XTALPI.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.